Osaic Holdings’s Sonoma Pharmaceuticals SNOA Stock Holding History
Bought
Maintained
Sold
Other funds holding SNOA
MCWS
GRP
Osaic Holdings's SNOA Position: Q2 2026 in Review
Osaic Holdings held its Sonoma Pharmaceuticals (SNOA) position steady in Q2 2026 at 500 shares worth $615. The position accounts for ﹤0.01% of the portfolio, ranked #7608.
Osaic Holdings first reported a position in SNOA in Q1 2020 and has held it in 20 quarters since. The position peaked at $2K in Q1 2021. 14 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.
- Osaic Holdings held 500 shares of Sonoma Pharmaceuticals worth $615 as of Q2 2026.
- Osaic Holdings left its Sonoma Pharmaceuticals share count unchanged in Q2 2026.
- Sonoma Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7608 holding.
- Osaic Holdings first reported a position in Sonoma Pharmaceuticals in Q1 2020 and has held it in 20 quarters since.
- Osaic Holdings's Sonoma Pharmaceuticals position peaked at $2K in Q1 2021.
- 14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.